Evaluation of the GORE® C3 Delivery System Module
This is an observational Registry designed to obtain early data on the use of the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Global Registry for Endovascular Aortic Treatment(GREAT)|
- Evaluate procedural outcomes for the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System when used in accordance with the standard medical practice at each participating hospital. [ Time Frame: Up to 10 Years ] [ Designated as safety issue: No ]
|Study Start Date:||January 2011|
|Estimated Study Completion Date:||November 2022|
|Primary Completion Date:||November 2012 (Final data collection date for primary outcome measure)|
Indication for aortic endovascular stent graft repair
Device: Stent graft (EXCLUDER)
Other Name: EXCLUDER
This is a retrospective and prospective observational cohort Registry designed to obtain data on the use of the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System. Patient and device performance outcomes will be collected during treatment and throughout all post-treatment visits, including follow-up extending up to 10 years.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01398332
|Nurnberg, Germany, 90471|
|Principal Investigator:||Eric Verhoeven, MD||Klinikum Nürnberg-Süd|